Literature DB >> 10688833

Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality.

H Soudeyns1, G Campi, G P Rizzardi, C Lenge, J F Demarest, G Tambussi, A Lazzarin, D Kaufmann, G Casorati, L Corey, G Pantaleo.   

Abstract

Major T-cell receptor beta chain variable region (TCRBV) repertoire perturbations are temporally associated with the down-regulation of viremia during primary human immunodeficiency virus (HIV) infection and with oligoclonal expansion and clonal exhaustion of HIV-specific cytotoxic T lymphocytes (CTLs). To determine whether initiation of antiretroviral therapy (ART) or highly active antiretroviral therapy (HAART) during primary infection influences the dynamics of T-cell-mediated immune responses, the TCRBV repertoire was analyzed by semiquantitative polymerase chain reaction in serial blood samples obtained from 11 untreated and 11 ART-treated patients. Repertoire variations were evaluated longitudinally. Stabilization of the TCRBV repertoire was more consistently observed in treated as compared with untreated patients. Furthermore, the extent and the rapidity of stabilization were significantly different in treated versus untreated patients. TCRBV repertoire stabilization was positively correlated with the slope of HIV viremia in the treated group, suggesting an association between repertoire stabilization and virologic response to treatment. To test whether stabilization was associated with variations in the clonal complexity of T-cell populations, T-cell receptor (TCR) heteroduplex mobility shift assays (HMAs) were performed on sequential samples from 4 HAART-treated subjects. Densitometric analysis of HMA profiles showed a reduction in the number of TCR clonotypes in most TCRBV families and a significant decrease in the total number of clonotypes following 7 months of HAART. Furthermore, a biphasic decline in HIV-specific but not heterologous CTL clones was observed. This indicates that ART leads to a global reduction of CD8(+) T-cell oligoclonality and significantly modulates the mobilization of HIV-specific CTL during primary infection. (Blood. 2000;95:1743-1751)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10688833

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire.

Authors:  Dirk Meyer-Olson; Kristen W Brady; Melissa T Bartman; Kristin M O'Sullivan; Brenna C Simons; Joseph A Conrad; Coley B Duncan; Shelly Lorey; Atif Siddique; Rika Draenert; Marylyn Addo; Marcus Altfeld; Eric Rosenberg; Todd M Allen; Bruce D Walker; Spyros A Kalams
Journal:  Blood       Date:  2005-12-01       Impact factor: 22.113

2.  Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among HIV-1 infected individuals before and after antiretroviral therapy.

Authors:  Carmem Beatriz Wagner Giacoia-Gripp; Ivan Neves; Maria Clara Galhardo; Mariza Gonçalves Morgado
Journal:  J Clin Immunol       Date:  2005-03       Impact factor: 8.317

3.  T-cell re-population in HIV-infected children on highly active anti-retroviral therapy (HAART).

Authors:  D J King; F M Gotch; E L Larsson-Sciard
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

4.  Fluidity of HIV-1-specific T-cell responses during acute and early subtype C HIV-1 infection and associations with early disease progression.

Authors:  Mandla Mlotshwa; Catherine Riou; Denis Chopera; Debra de Assis Rosa; Roman Ntale; Florette Treunicht; Zenda Woodman; Lise Werner; Francois van Loggerenberg; Koleka Mlisana; Salim Abdool Karim; Carolyn Williamson; Clive M Gray
Journal:  J Virol       Date:  2010-09-08       Impact factor: 5.103

5.  Clonal evolution of CD8+ T-cell expansions in HIV-infected patients on long-term HAART.

Authors:  D J King; E L Larsson-Sciard
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

6.  Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection.

Authors:  Mathias Lichterfeld; Xu G Yu; Stanley K Mui; Katie L Williams; Alicja Trocha; Mark A Brockman; Rachel L Allgaier; Michael T Waring; Tomohiko Koibuchi; Mary N Johnston; Daniel Cohen; Todd M Allen; Eric S Rosenberg; Bruce D Walker; Marcus Altfeld
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

Review 7.  Diagnostic role of tests for T cell receptor (TCR) genes.

Authors:  E Hodges; M T Krishna; C Pickard; J L Smith
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

8.  Differential tissue-specific regulation of antiviral CD8+ T-cell immune responses during chronic viral infection.

Authors:  Shenghua Zhou; Rong Ou; Lei Huang; Graeme E Price; Demetrius Moskophidis
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  Effect of IL-2 therapy on CD8+ cell noncytotoxic anti-HIV response during primary HIV-1 infection.

Authors:  B Martinez-Mariño; B M Ashlock; S Shiboski; F M Hecht; J A Levy
Journal:  J Clin Immunol       Date:  2004-03       Impact factor: 8.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.